Filing Details
- Accession Number:
- 0000950142-10-000405
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-10 12:00:00
- Reporting Period:
- 2010-03-08
- Filing Date:
- 2010-03-10
- Accepted Time:
- 2010-03-10 18:53:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1401923 | Map Pharmaceuticals Inc. | MAPP | Pharmaceutical Preparations (2834) | 200507047 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1237655 | Sfm Ah Llc | 888 Seventh Avenue 31St Floor New York NY 10106 | No | No | Yes | No | |
| 1253598 | Sfm Participation Lp | 888 Seventh Avenue 31St Floor New York NY 10106 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-03-08 | 3,155 | $14.61 | 2,826,803 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Disposition | 2010-03-09 | 634 | $15.40 | 2,826,169 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
Footnotes
- The price shown in Column 4 is a weighted average sale price. The price range for the sales is $14.20 to $14.80. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- All of the securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros"), Perseus-Soros Partners, LLC ("Perseus-Soros Partners"), the general partner of Perseus-Soros, SFM Participation, L.P ("SFM Participation"), a managing member of Perseus-Soros Partners, and Biotech Management Partners, LLC ("Biotech Management Partners"). SFM Participation is a managing member of Biotech Management Partners. SFM AH, LLC ("SFM AH"), is the general partner of SFM Participation.
- Represents 3,155 shares of the Issuer's Common Stock sold by SFM Participation. After the sale, SFM Participation owns directly 634 shares of the Issuer's Common Stock.
- The price shown in Column 4 is a weighted average sale price. The price range for the sales is $14.70 to $15.56. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents 634 shares of the Issuer's Common Stock sold by SFM Participation. After the sale, SFM Participation owns directly no shares of the Issuer's Common Stock
Billionaire Hedge Funds
